scientist in laboratory
Zejula Resources

A collection of resources, including presentations from key experts discussing the management of ovarian cancer within the UK and debating the relevance and implications of ‘hot topics’ in patient care.

Video player requires JavaScript enabled. You can download this video here: http://videos.gskstatic.com/pharma/GSKpro/UK/mp4/national-launch-event-pm-gb-nrp-vid-210001.mp4

Impacting UK clinical practice: Zejula for first-line maintenance treatment of advanced ovarian cancer

Professor Jonathan Ledermann
Professor Bradley Monk
Dr Rowan Miller 
Dr Shibani Nicum 

How is COVID-19 affecting the treatment and management of ovarian cancer?

Professor Jonathan Lederman
Dr Rebecca Bowen
Christina Fotopoulou
Dr Marcia Hall

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.

February 2021 | PM-GB-NRP-WCNT-210002